Literature DB >> 21074359

Quality of assessment of randomized controlled trials in blood conservation after joint arthroplasty.

Rajrishi Sharma1, Forough Farrokhyar, Leslie L McKnight, Mohit Bhandari, Rudolph W Poolman, Anthony Adili.   

Abstract

Blood transfusion after joint arthroplasty occurs in up to two thirds of patients. We conducted a systematic review of the literature to determine the methodological quality of published randomized controlled trials (RCTs). We searched MEDLINE, EMBASE, and Cochrane to identify RCTs in arthroplasty with blood conservation as the primary outcome from 2001 to 2007. Methodological quality was evaluated using the Detsky index. We identified 62 RCTs. The mean Detsky score was 73% ± 14%. Epidemiology affiliation (P = .003), funding support (<.001), and year of publication (<.001) were the predictors of reporting quality, predicting 46% of the variability (R(2) = 0.46). This suggests poor reporting quality of trials in blood conservation. The inclusion of an epidemiologist or a biostatistician for the design of a trial is strongly recommended.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21074359     DOI: 10.1016/j.arth.2010.08.014

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

Review 1.  Use of intraoperative technology in total knee arthroplasty is not associated with reductions in postoperative pain.

Authors:  Andrew G Kim; Zachary Bernhard; Alexander J Acuña; Victoria S Wu; Atul F Kamath
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-08-19       Impact factor: 4.114

Review 2.  Periprosthetic joint infection rates across primary total hip arthroplasty surgical approaches: a systematic review and meta-analysis of 653,633 procedures.

Authors:  Alexander J Acuña; Michael T Do; Linsen T Samuel; Daniel Grits; Jesse E Otero; Atul F Kamath
Journal:  Arch Orthop Trauma Surg       Date:  2021-09-30       Impact factor: 2.928

3.  Limit allogeneic blood use with routine re-use of patient's own blood: a prospective, randomized, controlled trial in total hip surgery.

Authors:  Bregje J W Thomassen; Peter Pilot; Vanessa A B Scholtes; Josef G Grohs; Ketil Holen; Elvira Bisbe; Rudolf W Poolman
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

4.  De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Cynthia So-Osman; Ad A Kaptein; Anja van der Hout; M Elske van den Akker-van Marle; Ankie W M M Koopman-van Gemert; Albert Dahan; Rob G H H Nelissen; Thea P M M Vliet Vlieland; Leti van Bodegom-Vos
Journal:  Implement Sci       Date:  2014-04-23       Impact factor: 7.327

5.  Designing a strategy to implement cost-effective blood transfusion management in elective hip and knee arthroplasties: a study protocol.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Cynthia So-Osman; Thea P M Vliet Vlieland; Ankie W M M Koopman-van Gemert; Rob G H H Nelissen; Leti van Bodegom-Vos; A Brand; D P Engberts; W B van der Hout; A A Kaptein; J B A van Mourik
Journal:  Implement Sci       Date:  2012-06-30       Impact factor: 7.327

6.  Frequent use of blood-saving measures in elective orthopaedic surgery: a 2012 Dutch blood management survey.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Manon M Wentink; Cynthia So-Osman; Thea P M Vliet Vlieland; Ankie W M M Koopman-van Gemert; Rob G H H Nelissen; Leti Van Bodegom-Vos
Journal:  BMC Musculoskelet Disord       Date:  2013-08-05       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.